Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroupsTess Tomassen(Radboud University Nijmegen), Yvonne M.H. Versleijen‐Jonkers(Radboud University Nijmegen)Immunologic ResearchJanuary 19, 202210.1007/s12026-021-09259-4Cited by 15SaveCiteExport RISWatch citationsRelated PapersThe role of AXL and the <i>in vitro</i> activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma|Oncotarget|2014|47Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib|Targeted Oncology|2017|39